Full Text
The Full Text of this article is available as a PDF (20.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brinton L. A., Hoover R. N., Szklo M., Fraumeni J. F., Jr Menopausal estrogen use and risk of breast cancer. Cancer. 1981 May 15;47(10):2517–2522. doi: 10.1002/1097-0142(19810515)47:10<2517::aid-cncr2820471035>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
- Delmas P. D., Bjarnason N. H., Mitlak B. H., Ravoux A. C., Shah A. S., Huster W. J., Draper M., Christiansen C. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med. 1997 Dec 4;337(23):1641–1647. doi: 10.1056/NEJM199712043372301. [DOI] [PubMed] [Google Scholar]
- Fossati R., Confalonieri C., Torri V., Ghislandi E., Penna A., Pistotti V., Tinazzi A., Liberati A. Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol. 1998 Oct;16(10):3439–3460. doi: 10.1200/JCO.1998.16.10.3439. [DOI] [PubMed] [Google Scholar]
- Frankel S., Sterne J., Smith G. D. Mortality variations as a measure of general practitioner performance: implications of the Shipman case. BMJ. 2000 Feb 19;320(7233):489–489. doi: 10.1136/bmj.320.7233.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nomura A. M., Kolonel L. N., Hirohata T., Lee J. The association of replacement estrogens with breast cancer. Int J Cancer. 1986 Jan 15;37(1):49–53. doi: 10.1002/ijc.2910370109. [DOI] [PubMed] [Google Scholar]
- Osborne C. K. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998 Nov 26;339(22):1609–1618. doi: 10.1056/NEJM199811263392207. [DOI] [PubMed] [Google Scholar]
- Smith R. All changed, changed utterly. British medicine will be transformed by the Bristol case. BMJ. 1998 Jun 27;316(7149):1917–1918. doi: 10.1136/bmj.316.7149.1917. [DOI] [PMC free article] [PubMed] [Google Scholar]